Open Government Canada
Notice - Prescription Drug List (PDL): Triamcinolone acetonide
Published by Health Canada | Santé Canada
About this dataset
The purpose of this Notice of Amendment is to announce the revised listing for Adrenocortical hormones to allow the nonprescription use of triamcinolone acetonide for the conditions listed below. Only the Human part of the PDL has been revised.